Painceptor Pharma Corporation
Records under this name other than patents Painceptor Pharma Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Painceptor Pharma Corporation
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,718,641 | Pyrrolo [3,4-H] isoquinoline compounds and methods for modulating gated ion channels Formerly held Lapsed on the fee record Ended May 18, 2018 · USPTO record | Lapsed on the fee record | Ended May 18, 2018 | USPTO record |
| US 6,727,260 | Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders Formerly held Lapsed on the fee record Ended Apr 27, 2016 · USPTO record | Lapsed on the fee record | Ended Apr 27, 2016 | USPTO record |
| US 7,288,653 | Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders Formerly held Lapsed on the fee record Ended Oct 30, 2015 · USPTO record | Lapsed on the fee record | Ended Oct 30, 2015 | USPTO record |
| US 7,579,468 | Methods of modulating neurotrophin-mediated activity Lapsed on the fee record Ended Aug 25, 2013 · USPTO record | Lapsed on the fee record | Ended Aug 25, 2013 | USPTO record |
| US 7,291,629 | Neurotrophin antagonist compositions Lapsed on the fee record Ended Nov 6, 2011 · USPTO record | Lapsed on the fee record | Ended Nov 6, 2011 | USPTO record |